770 related articles for article (PubMed ID: 29021413)
1. CyberKnife Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy As First-line Treatments for Imaging-diagnosed Intracranial Meningiomas.
Manabe Y; Murai T; Ogino H; Tamura T; Iwabuchi M; Mori Y; Iwata H; Suzuki H; Shibamoto Y
Neurol Med Chir (Tokyo); 2017 Dec; 57(12):627-633. PubMed ID: 29021413
[TBL] [Abstract][Full Text] [Related]
2. Intracranial meningioma: Experience with stereotactic radiotherapy.
Ragos V; Yazici O; Guzle Adas Y; Kekilli E; Calikoglu T; Bedri Altundag M; Riza Ucer A; Ertas G; Durmus Duzgun S; Ozbagi K; Demirkasimoglu A; Demir E; Aslan B; Kaya B
J BUON; 2018; 23(4):1169-1173. PubMed ID: 30358227
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic radiosurgery for WHO grade I posterior fossa meningiomas: long-term outcomes with volumetric evaluation.
Patibandla MR; Lee CC; Tata A; Addagada GC; Sheehan JP
J Neurosurg; 2018 Nov; 129(5):1249-1259. PubMed ID: 29303453
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of fractionated stereotactic radiotherapy for intracranial skull base benign meningiomas in single institution.
Onodera S; Aoyama H; Katoh N; Taguchi H; Yasuda K; Yoshida D; Surtherland K; Suzuki R; Ishikawa M; Gerard B; Terasaka S; Shirato H
Jpn J Clin Oncol; 2011 Apr; 41(4):462-8. PubMed ID: 21177777
[TBL] [Abstract][Full Text] [Related]
5. Indications, feasibility, safety, and efficacy of CyberKnife radiotherapy for the treatment of olfactory groove meningiomas: a single institutional retrospective series.
Liu J; Rojas R; Lam FC; Mirza FA; Mahadevan A; Kasper EM
Radiat Oncol; 2020 Mar; 15(1):63. PubMed ID: 32164781
[TBL] [Abstract][Full Text] [Related]
6. Is Fractionated Gamma Knife Radiosurgery a Safe and Effective Treatment Approach for Large-Volume (>10 cm
Han MS; Jang WY; Moon KS; Lim SH; Kim IY; Jung TY; Jung S
World Neurosurg; 2017 Mar; 99():477-483. PubMed ID: 28017757
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of perioptic tumors treated with hypofractionated stereotactic radiotherapy using CyberKnife® stereotactic radiosurgery.
Puataweepong P; Dhanachai M; Hansasuta A; Dangprasert S; Sitathanee C; Ruangkanchanasetr R; Yongvithisatid P
J Neurooncol; 2018 Sep; 139(3):679-688. PubMed ID: 29846895
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiosurgery versus stereotactic radiotherapy in the management of intracranial meningiomas: a systematic review and meta-analysis.
Fatima N; Meola A; Pollom EL; Soltys SG; Chang SD
Neurosurg Focus; 2019 Jun; 46(6):E2. PubMed ID: 31153149
[TBL] [Abstract][Full Text] [Related]
9. Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis.
Alfredo C; Carolin S; Güliz A; Anne K; Antonio P; Alberto C; Stefano P; Antonino G; Harun B; Markus K; Franziska M; Phuong N; Franziska L; Peter V; Volker B; David K
Radiat Oncol; 2019 Nov; 14(1):201. PubMed ID: 31718650
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated Stereotactic Radiotherapy for the Treatment of Benign Intracranial Meningiomas: Long-Term Safety and Efficacy.
Nguyen EK; Pond GR; Greenspoon JN; Whitton AC; Hann C
Curr Oncol; 2021 Sep; 28(5):3683-3691. PubMed ID: 34590613
[TBL] [Abstract][Full Text] [Related]
11. Significance of tumor volume related to peritumoral edema in intracranial meningioma treated with extreme hypofractionated stereotactic radiation therapy in three to five fractions.
Morimoto M; Yoshioka Y; Shiomi H; Isohashi F; Konishi K; Kotsuma T; Fukuda S; Kagawa N; Kinoshita M; Hashimoto N; Yoshimine T; Koizumi M
Jpn J Clin Oncol; 2011 May; 41(5):609-16. PubMed ID: 21411468
[TBL] [Abstract][Full Text] [Related]
12. Radiosurgery and stereotactic radiotherapy for intracranial meningiomas.
Torres RC; Frighetto L; De Salles AA; Goss B; Medin P; Solberg T; Ford JM; Selch M
Neurosurg Focus; 2003 May; 14(5):e5. PubMed ID: 15669816
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated stereotactic radiosurgery: a new treatment strategy for giant cavernous sinus hemangiomas.
Wang X; Zhu H; Knisely J; Mei G; Liu X; Dai J; Mao Y; Pan L; Qin Z; Wang E
J Neurosurg; 2018 Jan; 128(1):60-67. PubMed ID: 28298046
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic Radiosurgery of Central Skull Base Meningiomas-Volumetric Evaluation and Long-Term Outcomes.
Patibandla MR; Lee CC; Sheehan J
World Neurosurg; 2017 Dec; 108():176-184. PubMed ID: 28882711
[TBL] [Abstract][Full Text] [Related]
15. Cranial nerve outcomes after primary stereotactic radiosurgery for symptomatic skull base meningiomas.
Faramand A; Kano H; Niranjan A; Johnson SA; Hassib M; Park KJ; Arai Y; Flickinger JC; Lunsford LD
J Neurooncol; 2018 Sep; 139(2):341-348. PubMed ID: 29691775
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of stereotactic radiosurgery, hypofractionated, and fractionated stereotactic radiotherapy in the treatment of skull base meningioma.
Han J; Girvigian MR; Chen JC; Miller MJ; Lodin K; Rahimian J; Arellano A; Cahan BL; Kaptein JS
Am J Clin Oncol; 2014 Jun; 37(3):255-60. PubMed ID: 23241504
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of moderate hypofractionated stereotactic radiotherapy for meningiomas.
Maranzano E; Draghini L; Casale M; Arcidiacono F; Anselmo P; Trippa F; Giorgi C
Strahlenther Onkol; 2015 Dec; 191(12):953-60. PubMed ID: 26490452
[TBL] [Abstract][Full Text] [Related]
18. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
[TBL] [Abstract][Full Text] [Related]
19. CyberKnife Stereotactic Radiosurgery for Atypical and Malignant Meningiomas.
Zhang M; Ho AL; D'Astous M; Pendharkar AV; Choi CY; Thompson PA; Tayag AT; Soltys SG; Gibbs IC; Chang SD
World Neurosurg; 2016 Jul; 91():574-581.e1. PubMed ID: 27108030
[TBL] [Abstract][Full Text] [Related]
20. The "Combo" radiotherapy treatment for high-risk grade 2 meningiomas: dose escalation and initial safety and efficacy analysis.
Pontoriero A; Critelli P; Conti A; Cardali S; Angileri FF; Germanò A; Lillo S; Carretta A; Brogna A; Santacaterina A; Parisi S; Pergolizzi S
J Neurooncol; 2023 Jan; 161(2):203-214. PubMed ID: 35927392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
